TTI-101
Showing 1 - 25 of 698
Pancreatic Cancer Trial in Aurora (TTI-101)
Not yet recruiting
- Pancreatic Cancer
- TTI-101
-
Aurora, ColoradoUniversity of Colorado
Nov 30, 2023
Idiopathic Pulmonary Fibrosis Trial (TTI-101, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- TTI-101
- Placebo
- (no location specified)
Jan 3, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Control Group
- TTI-101
-
Houston, TexasM D Anderson Cancer Centerl
Apr 25, 2023
Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))
Recruiting
- Breast Cancer
- TTI-101
- +2 more
-
Saint Louis, Missouri
- +2 more
Jan 12, 2023
Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- TTI-101
- Pembrolizumab
- (no location specified)
Dec 20, 2022
Hepatocellular Carcinoma Trial (TTI-101, Pembrolizumab, Atezolizumab)
Not yet recruiting
- Hepatocellular Carcinoma
- TTI-101
- +3 more
- (no location specified)
Jun 30, 2022
Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer Trial in Atlanta, Houston, San Antonio
Recruiting
- Breast Cancer
- +7 more
- TTI-101
-
Atlanta, Georgia
- +2 more
Jun 13, 2022
Multiple Myeloma Trial in United States (TTI-622, Daratumumab Hyaluronidase-fihj)
Recruiting
- Multiple Myeloma
- TTI-622
- Daratumumab Hyaluronidase-fihj
-
Basking Ridge, New Jersey
- +6 more
Dec 8, 2022
Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between
Not yet recruiting
- Recurrent ALK Positive Large B-Cell Lymphoma
- +28 more
- Biospecimen Collection
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 17, 2022
COVID-19, COVID-19 Acute Respiratory Distress Syndrome Trial (TTI-0102, Placebo)
Not yet recruiting
- COVID-19
- COVID-19 Acute Respiratory Distress Syndrome
- TTI-0102
- Placebo
- (no location specified)
May 13, 2022
Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)
Not yet recruiting
- Chronic Hepatitis b
- AB-101
- +2 more
-
Auckland, New ZealandNew Zealand Clinical Research Auckland
Jul 26, 2023
Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)
Not yet recruiting
- Nasopharyngeal Carcinoma
- KSD-101
-
Wuhan, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 19, 2023
Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)
Recruiting
- Lymphoma, B-Cell
- Chronic Lymphocytic Leukemia
- FT596
- +4 more
-
Chicago, Illinois
- +8 more
Jun 21, 2022
Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)
Recruiting
- Frontotemporal Dementia
- +3 more
- Intrathalamic AAV.PGRN administration
- Intrathalamic AVB-101
-
Katowice, Poland
- +3 more
Oct 6, 2023
Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -
Completed
- Nonalcoholic Fatty Liver Disease
- Anti-human CCL24 monoclonal antibody (CM-101) - Part One
- +3 more
-
Jerusalem, IsraelHadassah University Hospital - Ein Kerem
Sep 13, 2023
Cancer Trial (Antibody-Drug Conjugate)
Not yet recruiting
- Cancer
- Antibody-Drug Conjugate
- (no location specified)
Aug 23, 2023
Community-acquired Pneumonia, Bacterial Pneumonia Trial in Cincinnati (CMTX-101, Placebo)
Recruiting
- Community-acquired Pneumonia
- Bacterial Pneumonia
- CMTX-101
- Placebo
-
Cincinnati, OhioMedpace Clinical Pharmacology Unit
Jan 20, 2023
Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical
Not yet recruiting
- Epidermolysis Bullosa
- +2 more
- EB-101 Surgical application of RDEB wounds
-
Redwood City, California
- +1 more
Feb 13, 2023
NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)
Not yet recruiting
- NSCLC
- +5 more
- CJRB-101
- Pembrolizumab injection
- (no location specified)
Jun 1, 2023
Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,
Not yet recruiting
- Idiopathic Inflammatory Myopathies
- +3 more
- KYV-101
- +2 more
- (no location specified)
Nov 21, 2023
Metastatic Lung Cancer Trial in France (InvisionFirstĀ® molecular panel)
Active, not recruiting
- Metastatic Lung Cancer
- InvisionFirstĀ® molecular panel
-
Bayeux, France
- +15 more
Aug 22, 2022
Orthostatic Hypotension Trial in Newcastle Upon Tyne (ISO-101)
Not yet recruiting
- Orthostatic Hypotension
- ISO-101
-
Newcastle Upon Tyne, United KingdomFalls and Syncope Service, Older People's Medicine, The Newcastl
Sep 8, 2023